Cargando…
Extrapolation of Survival Curves from Cancer Trials Using External Information
Background: Estimates of life expectancy are a key input to cost-effectiveness analysis (CEA) models for cancer treatments. Due to the limited follow-up in Randomized Controlled Trials (RCTs), parametric models are frequently used to extrapolate survival outcomes beyond the RCT period. However, diff...
Autores principales: | Guyot, Patricia, Ades, Anthony E., Beasley, Matthew, Lueza, Béranger, Pignon, Jean-Pierre, Welton, Nicky J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190619/ https://www.ncbi.nlm.nih.gov/pubmed/27681990 http://dx.doi.org/10.1177/0272989X16670604 |
Ejemplares similares
-
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
por: Guyot, Patricia, et al.
Publicado: (2012) -
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
por: Lueza, Béranger, et al.
Publicado: (2016) -
Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
por: Lueza, Béranger, et al.
Publicado: (2016) -
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study
por: Lueza, Béranger, et al.
Publicado: (2016) -
External validity of rct evidence in cost-effectiveness analyses. A review of recent technology appraisals for nice and proposed methods of adjustment
por: Mantopoulos, Theodoros, et al.
Publicado: (2015)